Healthspan Collective

Peptides on the Docket

Recorded July 25, 202645 min

Elias Arjan · Gayland Hethcoat

Over two days (July 23–24), the FDA's Pharmacy Compounding Advisory Committee weighed in on some of the most talked-about peptides in longevity — BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon — as it considered whether they belong on the 503A Bulks List for compounding pharmacies. Elias Arjan sits down with attorney Gayland Hethcoat of ArentFox Schiff to unpack what the committee recommended, what it doesn't decide, and what it means for compounders, clinicians, and companies working with these substances.